In recent years, non-coding RNAs—especially microRNAs (miRNAs) and long non-coding RNAs (lncRNAs)—have emerged as powerful regulators of cellular behavior. These molecules modulate gene expression, often by targeting mRNAs for translational suppression or degradation. Two recent studies—one focused on osteoarthritis and the other on 5-Fu-resistant colorectal cancer—illustrate how these non-coding, regulatory RNAs operate within disease-relevant signaling networks, providing new points for therapeutic intervention.

Both studies use the pmirGLO Dual-Luciferase miRNA Target Expression Vector to evaluation predicted miRNA activity.  This dual-luciferase system offers a clean and quantifiable way to validate miRNA–mRNA interactions using a simple bioluminescent readout. By cloning the 3´ untranslated regions (UTRs) of suspected targets downstream of a firefly luciferase reporter and normalizing against Renilla luciferase, researchers can rapidly confirm whether a miRNA directly regulates its target.

Continue reading “Using Dual-Luciferase Assays to Identify the Role of Non-Coding RNAs in Disease”